Boardroom Alpha Digest: Thurs, Jan 5

by | Jan 5, 2023

Executive News

  • Stitch Fix (SFIX) CEO Elizabeth Spaulding has resigned after having just taken the post in August 2021. Co-Founder and former CEO Katrina Lake returns as Interim CEO until the company finds a replacement. SFIX also announced 20% layoffs in its workforce
  • David Flitman officially took over as CEO of US Foods (USFD) replacing Andrew Iacobucci in a move that was announced in November

Activism Situations

  • Impactive Capital has officially nominated 4 directors to the board of Envestnet, Inc. (ENV). The firm cites underperformance, poor governance and lack of shareholder alignment as its catalysts, and follows a letter the company sent the board last November. See the proxy here.

IPOS

  • Johnson & Johnson (JNJ)‘s Consumer Health arm Kenvue Inc. has filed for an IPO. The company has yet to set terms on the offering but boasts over $15.1B net sales for 2021 and includes “iconic brands Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec and Nicorette”

SPACs

  • For the second time this week a sponsor forfeited its private placement assets (Class A shares this time), in what some are calling a potential tax-loss harvesting play. In this case it was two’s (TWOA) sponsor
  • DTRT Health Acquisition Corp. (DTRT) and Consumer Direct Holdings terminated their merger agreement and DTRT announced that it will liquidate

SPAC Calendar

Recent Analysis

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.